FDA Seeks To Resolve First Amendment Suit By Pacira
This article was originally published in The Pink Sheet Daily
Executive Summary
Judge extends date for agency response to firm's complaint as parties continue settlement talks; case reveals two chinks in FDA’s off-label regulatory regime armor, former FDA advisor says.